Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2

Coronavirus Disease 2019 (COVID-19) is a highly infectious and pathogenic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early in this epidemic, the herbal formulas used in traditional Chinese medicine (TCM) were widely used for the treatment of COVID-19 in China...

Full description

Bibliographic Details
Main Authors: Ming-Feng He, Jian-Hui Liang, Yan-Ni Shen, Jin-Wen Zhang, Ying Liu, Kuang-Yang Yang, Li-Chu Liu, Junyi Wang, Qian Xie, Chun Hu, Xun Song, Yan Wang
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Life
Subjects:
SARS-CoV-2
ACE2
glycyrrhizin
spike protein RBD
Online Access:https://www.mdpi.com/2075-1729/12/11/1706

Internet

https://www.mdpi.com/2075-1729/12/11/1706

Similar Items